{"disease":{"id":"optic-neuritis-with-demyelination","name":"optic neuritis with demyelination"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03536559","title":"Nanocrystalline Gold to Treat Remyelination Failure in Chronic Optic Neuropathy In Multiple Sclerosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":73,"lead_sponsor_name":"Clene Nanomedicine","has_results":false},{"nct_id":"NCT03630497","title":"BN201 SAD MAD Study in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Accure Therapeutics","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}